Rapid and simple detection of hot spot point mutations of epidermal growth factor receptor, BRAF, and NRAS in cancers using the loop-hybrid mobility shift assay

48Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Abstract

A simple and rapid method to detect the epidermal growth factor receptor hot spot mutation L858R in lung adenocarcinoma was developed based on principles similar to the universal heteroduplex generator technology. A single-stranded oligonucleotide with an internal deletion was used to generate heteroduplexes (loop-hybrids) bearing a loop in the complementary strand derived from the polymerase chain reaction product of the normal or mutant allele. By placing deletion in the oligonucleotide adjacent to the mutational site, difference in electrophoretic mobility between loop-hybrids with normal and mutated DNA was distinguishable in a native polyacrylamide gel. The method was also modified to detect in-frame deletion mutations of epidermal growth factor receptor in lung adenocarcinomas. In addition, the method was adapted to detect hot spot mutations in the B-type Raf kinase (BRAF) at V600 and in a Ras-oncogene (NRAS) at Q61, the mutations commonly found in thyroid carcinomas. Our mutation detection system, designated the loop-hybrid mobility shift assay was sensitive enough to detect mutant DNA comprising 7.5% of the total DNA. As a simple and straightforward mutation detection technique, loop-hybrid mobility shift assay may be useful for the molecular diagnosis of certain types of clinical cancers. Other applications are also discussed. Copyright © American Society for Investigative Pathology and the Association for Molecular Pathology.

References Powered by Scopus

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non-Small-Cell Lung Cancer to Gefitinib

10534Citations
N/AReaders
Get full text

Mutations of the BRAF gene in human cancer

9022Citations
N/AReaders
Get full text

EGFR mutations in lung, cancer: Correlation with clinical response to gefitinib therapy

8911Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Epidermal growth factor receptor mutation testing in lung cancer: Searching for the ideal method - Commentary on Hoshi et al., p. 4974

196Citations
N/AReaders
Get full text

Assessment of epidermal growth factor receptor mutation by endobronchial ultrasound-guided transbronchial needle aspiration

191Citations
N/AReaders
Get full text

Distinctive evaluation of nonmucinous and mucinous subtypes off bronchioloalveolar carcinomas in EGFR and K-ras gene-mutation analyses for Japanese lung adenocarcinomas: Confirmation of the correlations with histologic subtypes and gene mutations

122Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Matsukuma, S., Yoshihara, M., Kasai, F., Kato, A., Yoshida, A., Akaike, M., … Miyagi, Y. (2006). Rapid and simple detection of hot spot point mutations of epidermal growth factor receptor, BRAF, and NRAS in cancers using the loop-hybrid mobility shift assay. Journal of Molecular Diagnostics, 8(4), 504–512. https://doi.org/10.2353/jmoldx.2006.060030

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 8

62%

Researcher 3

23%

Professor / Associate Prof. 2

15%

Readers' Discipline

Tooltip

Medicine and Dentistry 7

54%

Agricultural and Biological Sciences 3

23%

Biochemistry, Genetics and Molecular Bi... 2

15%

Pharmacology, Toxicology and Pharmaceut... 1

8%

Save time finding and organizing research with Mendeley

Sign up for free